Bhang Inc (BHNGF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Bhang Cash from Operations (Quarterly): -0.2664M for Sept. 30, 2022
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2022 | -0.2664M |
June 30, 2022 | -0.5148M |
March 31, 2022 | -0.4371M |
December 31, 2021 | -0.7831M |
September 30, 2021 | -0.2705M |
June 30, 2021 | -0.7248M |
March 31, 2021 | -0.3425M |
December 31, 2020 | -0.4983M |
September 30, 2020 | -0.3924M |
June 30, 2020 | -0.4346M |
March 31, 2020 | -0.8735M |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 |
Date | Value |
---|---|
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | 1.202M |
March 31, 2011 | -0.6252M |
December 31, 2010 | -0.577M |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 | |
December 31, 2009 |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-0.8735M
Minimum
Mar 2020
-0.2664M
Maximum
Sep 2022
-0.5034M
Average
-0.4371M
Median
Mar 2022
Cash from Operations (Quarterly) Benchmarks
Cantabio Pharmaceuticals Inc | -0.2582M |
Affymax Inc | -- |
Scopus BioPharma Inc | -1.009M |
Predictive Technology Group Inc | -3.366M |
Statera BioPharma Inc | -0.8015M |
Cash from Operations (Quarterly) Related Metrics
Cash from Financing (Quarterly) | 0.0557M |